DLD associated with Oncologic Disorders* |
65 (21.2%) |
8 ±
4.8 |
Bronchiolitis Obliterans (not HSCT or oncology related) |
31 (10.1%) |
5.3 ± 4.8 |
DLD associated with Connective Tissue Diseases** |
29 (9.5%) |
8.4
± 5.3 |
Neuroendocrine cell Hyperplasia of Infancy |
28 (9.2%) |
1.9 ±
2.7 |
Environmental/Toxic related*** |
27 (8.8%) |
17.3 ±
1.6 |
Alveolar Hemorrhage Disorders |
23 (7.5%) |
4.5 ±
2.6 |
Surfactant Metabolic Dysfunction |
19 (6.2%) |
2.5 ±
4.3 |
DLD associated with Immune-related Disorders#
|
15
(4.9%) |
7.0 ± 4.9 |
Ataxia Telangiectasia |
8 (2.6%) |
4.8 ± 2.9 |
Diffuse Lung Disease NOS
ILD NOS
Vascular Disease NOS
Cystic Lung Disease NOS
Developmental Lung Disease NOS
|
32 (10.5%)
23 (7.5%)
5 (1.6%)
3 (1%)
1 (<1%)
|
n/a
|
Others$
|
29 (9.5%) |
n/a |